Αρχική Uncategorized Doctors Worry Breast Cancer Cases Are Being Missed as Mammogram Rates Plummet...

Doctors Worry Breast Cancer Cases Are Being Missed as Mammogram Rates Plummet During Pandemic

With hospitals scaling back offered procedures and the fear of contracting COVID-19 in hospitals, many people have been forgoing annual health screenings throughout the pandemic. Among those procedures being avoided is mammograms. A recent study out of California found that this year, women have been less apt to get their mammograms and more apt to receive a diagnosis in the later stages of the disease. Doctors are using this information to encourage women not to put off this important preventative tool.

A study presented at the San Antonio Breast Cancer Symposium last month showed that during the shelter-in-place stretch last spring in California, the number of new diagnoses at the Kaiser Permanente System was down 64% compared with the same time period in 2020, from 703 to 250. Dr. Annie Tang, researcher with Kaiser’s Northern California Permanente Medical Group Breast Cancer Collaborative, says this lead to worries that women who would have otherwise been diagnosed, weren’t.

PHOTO: PIXABAY/JURAJ VARGA

Tang explains there were changes put in place for the pandemic, saying, “Breast cancer guidelines were developed within our large integrated health care system of 22 hospitals, all outreach for mammography screenings were held but women who wished to have screening were still accommodated, elective surgeries were stopped, and cancer surgeries were continued.”

Of those who were screened and diagnosed, there was an increase in symptomatic cases, advanced stage cases, and aggressive cancers compared with 2019.

In light of worries about how the pandemic has impacted breast cancer diagnoses, health care providers across the country are urging women to continue to stay on top of health screenings.

Troy Koch, a radiologist at St. George Regional Hospital in Utah, says the trends of the Kaiser study are present in his facility, as well.

PHOTO: ADOBE STOCK/HERO IMAGES

He urges women, “Don’t delay for COVID. We’ve seen some patients in the spring and diagnosed some cancers that we probably would’ve diagnosed months sooner.”

Oncologist and genetics specialist Margaret Van Meter, who also works with the Intermountain Healthcare system in Utah, says those without symptoms could look into telehealth meetings for a consultation on their risk. Only testing and treatment need to occur in the hospital. If you find a lump, though, you should go immediately.

The American Cancer Society says nationwide, the vast majority of women are not getting their mammograms right now.

Dr. Carmen Guerra, a national board scientific officer with the American Cancer Society, says, “It’s plummeted down to about 10% of what we normally do. So that’s a 90% decline. Our grave concern is that we are not diagnosing cancers that are out there early when they are most treatable.”

PHOTO: PIXABAY/ENGIN AKYURT

She says this means health care professionals need to brace themselves for a surge of later-stage, advanced cases. The further the disease progresses, the less treatable it is, so outcomes for these new patients may not be so good.

This is something that could be avoided if women go in to get screened when they’re supposed to, which health care providers say is very safe.

Article continues below

Our Featured Programs

See how we’re making a difference for People, Pets, and the Planet and how you can get involved!

Dr. Guerra explains, “Please schedule your mammogram. The hospitals, the clinics, the mammography centers have taken completely different protocols to make mammographies safe.”

The American Cancer Society recommends that all women between 45 and 54 get a mammogram yearly, but they say those 55 and older may choose to wait up to two years after a normal mammogram, provided they are at average risk.

PHOTO: ADOBE STOCK/WAVEBREAKMEDIAMICRO

Provide Mammograms

Support those fighting Breast Cancer at The Breast Cancer Site for free!

Whizzco Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

10 Ways You Can Nurture A More Sustainable Garden

Sustainable gardening doesn’t have a firm, technical definition. It’s the concept of using sustainable gardening techniques that not only cause no harm to the...

Cancer Research UK spin-out gets US approval to trial unique T cell therapy

Cancer Research UK’s spin-out, GammaDelta Therapeutics (‘GammaDelta’), has been given approval from the US Food and Drug Administration (FDA) to trial its unique T-cell...

Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual TNBC Following Neoadjuvant Chemotherapy

The ECOG-ACRIN EA1131 study hypothesised that invasive disease-free survival (iDFS) would not be inferior but improved in patients with basal subtype triple-negative breast cancer...

Adding Checkpoint Inhibition to Anti-HER2 Breast Cancer Therapy Brings no Benefit [ESMO Virtual Plenary Press Release]

VP6-2021 - IMpassion050: A phase III study of neoadjuvant atezolizumab + pertuzumab + trastuzumab + chemotherapy (neoadj A + PH + CT) in high-risk,...

Breaking News: Supreme Court Upholds the Affordable Care Act

It’s a great day for cancer survivors. The Supreme Court of the United States (SCOTUS) upheld the Affordable Care Act (ACA), commonly known as...

How Does CAR T-Cell Therapy Work in Treating Cancer?

Craig A. Portell, MD, is an Associate Professor of Medicine at the University of Virginia and a member of the UVA Cancer Center in...